{"altmetric_id":398482,"counts":{"readers":{"mendeley":42,"citeulike":0,"connotea":0},"facebook":{"unique_users_count":1,"unique_users":["271025616302333"],"posts_count":1},"total":{"posts_count":12},"twitter":{"unique_users_count":9,"unique_users":["psumarydom","transplant_doc","sean_tiernan","mlazqui","osteoporose_nl","onkozentrum","myeloma_doc","mtmdphd","jsupportoncol"],"posts_count":11}},"selected_quotes":["Jaw osteonecrosis seen in 1.3% of 5723 cancer (including #myeloma) patients getting bisphosphonates or denosumab (","Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from thr... #myeloma #cancer","Incidence, risk factors, and outcomes of osteonecrosis of the jaw","ONJ bij 1,6% (89\/5723) patienten met botmetastasen behandeld met zoledronaat of denosumab zonder significant verschil"],"citation":{"abstract":"Osteonecrosis of the jaw (ONJ) has been reported in patients receiving bisphosphonates for metastatic bone disease. ONJ incidence, risk factors, and outcomes were evaluated in a combined analysis of three phase III trials in patients with metastatic bone disease receiving antiresorptive therapies.","abstract_source":"pubmed","altmetric_jid":"4f6fa4e83cf058f610002280","authors":["F. Saad","J. E. Brown","C. Van Poznak","T. Ibrahim","S. M. Stemmer","A. T. Stopeck","I. J. Diel","S. Takahashi","N. Shore","D. H. Henry","C. H. Barrios","T. Facon","F. Senecal","K. Fizazi","L. Zhou","A. Daniels","P. Carriere","R. Dansey","Saad F","Brown JE","Van Poznak C","Ibrahim T","Stemmer SM","Stopeck AT","Diel IJ","Takahashi S","Shore N","Henry DH","Barrios CH","Facon T","Senecal F","Fizazi K","Zhou L","Daniels A","Carri\u00e8re P","Dansey R"],"doi":"10.1093\/annonc\/mdr435","endpage":"1347","first_seen_on":"2011-10-11T06:19:57+00:00","funders":["cruk"],"issns":["0923-7534","1569-8041"],"issue":"5","journal":"Annals of Oncology","last_mentioned_on":1340073870,"links":["http:\/\/annonc.oxfordjournals.org\/content\/early\/2011\/10\/10\/annonc.mdr435.short?rss=1","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/21986094"],"pmid":"21986094","pubdate":"2011-10-10T00:00:00+00:00","publisher_subjects":[{"name":"Oncology And Carcinogenesis","scheme":"era"}],"scopus_subjects":["Medicine","Health Sciences"],"startpage":"1341","subjects":["neoplasms"],"title":"Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three blinded active-controlled phase III trials in cancer patients with bone metastases","type":"article","uri":"https:\/\/academic.oup.com\/annonc\/article-lookup\/doi\/10.1093\/annonc\/mdr435","volume":"23","mendeley_url":"http:\/\/www.mendeley.com\/research\/incidence-risk-factors-outcomes-osteonecrosis-jaw-integrated-analysis-three-blinded-activecontrolled-9"},"altmetric_score":{"score":5.5,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":5.5},"context_for_score":{"all":{"total_number_of_other_articles":6374656,"mean":5.986409401293,"rank":1007813,"this_scored_higher_than_pct":84,"this_scored_higher_than":5362413,"rank_type":"exact","sample_size":6374656,"percentile":84},"similar_age_3m":{"total_number_of_other_articles":71353,"mean":5.1672958291288,"rank":11980,"this_scored_higher_than_pct":83,"this_scored_higher_than":59262,"rank_type":"exact","sample_size":71353,"percentile":83},"this_journal":{"total_number_of_other_articles":2804,"mean":7.9015083838744,"rank":683,"this_scored_higher_than_pct":75,"this_scored_higher_than":2120,"rank_type":"exact","sample_size":2804,"percentile":75},"similar_age_this_journal_3m":{"total_number_of_other_articles":55,"mean":4.8377037037037,"rank":13,"this_scored_higher_than_pct":76,"this_scored_higher_than":42,"rank_type":"exact","sample_size":55,"percentile":76}}},"demographics":{"poster_types":{"member_of_the_public":4,"researcher":4,"practitioner":1},"users":{"twitter":{"cohorts":{"Scientists":4,"Members of the public":4,"Practitioners (doctors, other healthcare professionals)":1}},"mendeley":{"by_status":{"Professor > Associate Professor":3,"Librarian":1,"Researcher":6,"Student  > Doctoral Student":3,"Student  > Ph. D. Student":7,"Student  > Postgraduate":2,"Student  > Master":6,"Other":6,"Student  > Bachelor":7,"Lecturer":1},"by_discipline":{"Engineering":3,"Medicine and Dentistry":32,"Agricultural and Biological Sciences":3,"Biochemistry, Genetics and Molecular Biology":1,"Unspecified":2,"Veterinary Science and Veterinary Medicine":1}}},"geo":{"twitter":{"US":3,"GB":1,"ES":1,"NL":1}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/#!\/PSUMaryDom\/status\/124103466397335552","citation_ids":[398482],"posted_on":"2011-10-12T12:45:46+00:00","author":{"name":"Mary Dominiecki","image":"http:\/\/pbs.twimg.com\/profile_images\/1861513693\/1_normal.jpg","description":"Market researcher in healthcare, mother of 3 boys, cub scout leader, choir member, amateur photographer, soccer enthusiast, and volunteer.","id_on_source":"psumarydom","tweeter_id":"153824935","geo":{"lt":"39.952335","ln":"-75.163789","country":"US"},"followers":125},"tweet_id":"124103466397335552"},{"url":"http:\/\/twitter.com\/#!\/Transplant_Doc\/status\/124617215281598464","citation_ids":[398482],"posted_on":"2011-10-13T22:47:14+00:00","author":{"name":"Muzaffar Qazilbash","url":"http:\/\/faculty.mdanderson.org\/Muzaffar_Qazilbash\/Default.asp","image":"https:\/\/pbs.twimg.com\/profile_images\/1805143659\/Profile_compressed_pic-_020412_normal.jpg","description":"Stem Cell Transplant physician and clinical researcher at MD Anderson Cancer Center; special interest in myeloma. Opinions expressed are my own","id_on_source":"transplant_doc","tweeter_id":"162587280","geo":{"lt":null,"ln":null},"followers":3419},"tweet_id":"124617215281598464"},{"url":"http:\/\/twitter.com\/#!\/sean_tiernan\/status\/194836792183238656","citation_ids":[398482],"posted_on":"2012-04-24T17:14:45+00:00","author":{"name":"Sean Tiernan","url":"http:\/\/mylifewithmyeloma.blogspot.com","image":"https:\/\/pbs.twimg.com\/profile_images\/1552303712\/Sean_G__normal.png","description":"Professional Photographer covering portraiture, fashion, glamour and product photography. I'm also a Cancer patient  having ongoing treatment for Myeloma.","id_on_source":"sean_tiernan","tweeter_id":"36006306","geo":{"lt":53.1905,"ln":-2.89189,"country":"GB"},"followers":411},"tweet_id":"194836792183238656"},{"url":"http:\/\/twitter.com\/#!\/mlazqui\/status\/194923599876993024","citation_ids":[398482],"posted_on":"2012-04-24T22:59:42+00:00","author":{"name":"Mart\u00edn L\u00e1zaro","url":"http:\/\/www.novedadesenoncologia.blogspot.com","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000653691864\/11d6fb0c77217bfce2c907aa9b0f2ee5_normal.jpeg","description":"Medical oncologist. Lung and genitourinary cancer.","id_on_source":"mlazqui","tweeter_id":"196132848","geo":{"lt":42.23282,"ln":-8.72264,"country":"ES"},"followers":1703},"tweet_id":"194923599876993024"},{"url":"http:\/\/twitter.com\/#!\/mlazqui\/status\/123640328484962304","citation_ids":[398482],"posted_on":"2011-10-11T06:05:26+00:00","author":{"name":"Mart\u00edn L\u00e1zaro","url":"http:\/\/www.novedadesenoncologia.blogspot.com","image":"https:\/\/pbs.twimg.com\/profile_images\/378800000653691864\/11d6fb0c77217bfce2c907aa9b0f2ee5_normal.jpeg","description":"Medical oncologist. Lung and genitourinary cancer.","id_on_source":"mlazqui","tweeter_id":"196132848","geo":{"lt":42.23282,"ln":-8.72264,"country":"ES"},"followers":1703},"tweet_id":"123640328484962304"},{"url":"http:\/\/twitter.com\/#!\/Osteoporose_NL\/status\/124723860078731264","citation_ids":[398482],"posted_on":"2011-10-14T05:51:00+00:00","author":{"name":"Osteoporosis NL","image":"https:\/\/pbs.twimg.com\/profile_images\/2728406935\/efab446976f8d9558a2dd15208f7a5a6_normal.jpeg","description":"For public & professionals scientific news about osteoporosis and calcium & bone metabolism by Coen Netelenbos","id_on_source":"osteoporose_nl","tweeter_id":"213788861","geo":{"lt":52.5,"ln":5.75,"country":"NL"},"followers":1580},"tweet_id":"124723860078731264"},{"url":"http:\/\/twitter.com\/#!\/onkozentrum\/status\/123979704863703040","citation_ids":[398482],"posted_on":"2011-10-12T04:33:59+00:00","author":{"name":"OnkoZentrum Z\u00fcrich","url":"http:\/\/www.ozh.ch","image":"https:\/\/pbs.twimg.com\/profile_images\/401027494\/Panorama_6_normal.JPG","id_on_source":"onkozentrum","tweeter_id":"31080186","geo":{"lt":null,"ln":null},"followers":71},"tweet_id":"123979704863703040"},{"url":"http:\/\/twitter.com\/#!\/Myeloma_Doc\/status\/124100803546988544","citation_ids":[398482],"posted_on":"2011-10-12T12:35:11+00:00","author":{"name":"Robert Z. Orlowski","url":"http:\/\/faculty.mdanderson.org\/robert_orlowski\/","image":"https:\/\/pbs.twimg.com\/profile_images\/1118389100\/-1_normal.jpg","description":"Director of Myeloma Section at MD Anderson Cancer Center; Translational researcher who hates myeloma. Tweets are my own. Retweets \u2260 endorsements.","id_on_source":"myeloma_doc","tweeter_id":"187354183","geo":{"lt":29.76328,"ln":-95.36327,"country":"US"},"followers":7407},"tweet_id":"124100803546988544"},{"url":"http:\/\/twitter.com\/#!\/mtmdphd\/status\/124177712012206080","citation_ids":[398482],"posted_on":"2011-10-12T17:40:48+00:00","author":{"name":"Mike Thompson, MDPhD","url":"http:\/\/www.linkedin.com\/in\/michaelthompsonmdphd","image":"https:\/\/pbs.twimg.com\/profile_images\/2638189364\/9a817b84e5879a81121e476303368366_normal.png","description":"Heme\/Onc Researcher. @Aurora_Cancer Member: @ASCO @ASH_Hematology @Doximity. #mmsm, #lymsm, #ImmunoOnc, #ClinicalTrials Views=own","id_on_source":"mtmdphd","tweeter_id":"190337035","geo":{"lt":43.0389,"ln":-87.90647,"country":"US"},"followers":15405},"tweet_id":"124177712012206080"},{"url":"http:\/\/twitter.com\/#!\/JSupportOncol\/status\/124282381589942272","citation_ids":[398482],"posted_on":"2011-10-13T00:36:43+00:00","author":{"name":"Michael J. Fisch","url":"http:\/\/www.supportiveoncology.net\/","image":"http:\/\/a0.twimg.com\/profile_images\/1254198264\/JSO_cover.Jan-Feb2011_normal.jpg","description":"Tweeting on issues related to quality of life, symptoms, side effects, and palliative care. ","id_on_source":"jsupportoncol","tweeter_id":"257180076","followers":201},"tweet_id":"124282381589942272"},{"url":"http:\/\/twitter.com\/#!\/mtmdphd\/status\/124442317636632576","citation_ids":[398482],"posted_on":"2011-10-13T11:12:15+00:00","author":{"name":"Mike Thompson, MDPhD","url":"http:\/\/www.linkedin.com\/in\/michaelthompsonmdphd","image":"https:\/\/pbs.twimg.com\/profile_images\/2638189364\/9a817b84e5879a81121e476303368366_normal.png","description":"Heme\/Onc Researcher. @Aurora_Cancer Member: @ASCO @ASH_Hematology @Doximity. #mmsm, #lymsm, #ImmunoOnc, #ClinicalTrials Views=own","id_on_source":"mtmdphd","tweeter_id":"190337035","geo":{"lt":43.0389,"ln":-87.90647,"country":"US"},"followers":15405},"tweet_id":"124442317636632576"}],"facebook":[{"title":"Incidence, risk factors, and outcomes of osteonecrosis of the jaw: integrated analysis from three bl","url":"https:\/\/www.facebook.com\/permalink.php?story_fbid=402401006473511&id=271025616302333","citation_ids":[398482],"posted_on":"2012-06-19T02:44:30+00:00","summary":"Finally some decent research on incidence of ONJ with the use of bone-modifying drugs Aredia (pamidronate), Zometa (zoledronate), Prolia (denosumab) in MBC. Good news is incidence is quite low.","author":{"name":"AdvancedBC.org","url":"https:\/\/www.facebook.com\/271025616302333","facebook_wall_name":"AdvancedBC.org","image":"https:\/\/graph.facebook.com\/271025616302333\/picture","id_on_source":"271025616302333"}}]}}